The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ALT FINANCIAL STATEMENTS

Altimmune Inc — balance sheet, income statement and cash flow trends

ALTAltimmune Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M-50 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue31 K $Gross Profit-15 M $ · -48232%Operating Income-100.2 M $ · -323306%Pre-tax Income-91.8 M $ · -296000%Net Income to Owners-91.8 M $ · -296000%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue31 K $+55.0%
Gross Profit-15 M $-74,860.0%
Operating Income-100.2 M $—
EBITDA-88.1 M $—
Net Income to Owners-91.8 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets527.2 M
  • Equity474.2 M $90%
  • Current Liabilities12.5 M $2%
  • Long-term Liabilities40.5 M $8%

Key Figures

YoY change
Total Assets527.2 M $+177.0%
Total Liabilities53 M $+82.9%
Total Equity474.2 M $+193.9%
Cash & ST Investments326.3 M $+78.2%
Total Debt——
Net Debt-63 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0-76.5 M $Operating-453.6 M $Investing410 M $Financing-120.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-76.5 M $—
Capital Expenditures54 K $+440.0%
Free Cash Flow-76.6 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ALT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.